|
|
 |
|
| Home > Product > Product Information |
|
|
|
 Rupafin Tab. |
|
|
|
|
|
|
|
|
|
 |
|
Anti Histamine & Anti PAF Dual action, Fast onset time, High H1 receptor affinity |
|
 |
|
Allergic rhinitis, Urtinia (microthrepsia, pulmation, etc.) |
|
 |
|
Rupatadine purmate |
|
 |
|
A round yellow, pink, and raised crown |
|
 |
|
Ethical the Counter(ETC) |
|
 |
|
650204770 |
|
 |
|
279 |
|
|
|
|
|
|
|
|
|
|
4. General Attention
There was no effect on the operational and mechanical operation of the patients who were given this drug. However, this drug may cause drowsiness, so it is important to pay attention to the operation of the machine, etc., that can cause danger.
5. Interaction
1) Erisro misin and ketoconazole : When administered with 20mgL of rupatadine, ketoconazole, and erisin, the concentration of the blood increased tenfold. While this increase does not increase the QT aperture and adverse reactios, the drug should be carefully administered with attention to other CYP 3 A4 inhibitors.
2) Grapefruit : In combination with grapefruit juice, the blood concentration increased 3.5 times. Do not administer grapefruit juice together.
3) Alcohol : 10 mg of rupatadine with alcohol had a marginal effect on the psychomotor ability, but there was no noticeable difference between alcohol intake alone. The effect of alcohol on the spermatadine's ability to regulate movement increased when 20 milligrams of rupatadine.
4) Central nervous system inhibitor : As with any antihistamine, no interaction with central nervous system inhibitor can be ruled out.
5) Statins family of drugs : The clinical trial produced a number of non - performance-free CPK increases. The risks of interacting with statin-based medications are not clear, so use caution when administered in combination.
6. Medication
1) The drug has insufficient clinical data for pregnant women and has not demonstrated any direct or indirect adverse effects on pregnancy, fetus generation, or post-natal occurrence as a result of animal testing.
2) As animal tests report that the breast milk is transferred to the breast, it is desirable not to administer the medication to the nursing wife, but when this medicine is administered it is unavoidable, breast-feeding is necessary.
7. Administration of children
Safety and efficacy of this drug was not established in children under 12 years of age.
8. Administration for the Elderly
The institution carefully administered to elderly patients.
9. A patient with renal failure and liver failure
Safety and efficacy of this drug has not been established in patients with neuropathy and liver diseases.
10. Eliminate excess administration
No cases of over-injection were reported. No significant effects were observed in clinical trials, which administered 100 mg of rupatadine daily for six days, and the most frequent adverse events were drowsiness. Hypertension therapy and support therapy are recommended when taking excessive doses.
11. Storage and supply precautions
1) Keep the product out of the reach of children.
2) Store in the enclosure (casing) for protection against light.
|
|
|
|
 |
|
|
